Akèy › Obèsite › Florid › West Palm Beach
Etid klinik pou Obèsite nan West Palm Beach, FL
10 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote West Palm Beach (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Metabolic Research Institute /ID# 282350, West Palm Beach
- Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979, Lake Worth · 7 mi lwen
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Palm Beach Research Center, West Palm Beach
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Metabolic Research Institute, Inc., West Palm Beach
- JEM Research Institute, Atlantis · 9 mi lwen
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Cardiology Partners Clinical Research Institute, Palm Beach Gardens · 9 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- JEM Research Institute, Atlantis · 9 mi lwen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Cardiology Partners Clinical Research Institute, Wellington · 12 mi lwen
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Palm Beach Research Center, West Palm Beach
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- TruDerm & TruSpa, Wellington · 12 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Jupiter · 15 mi lwen
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Jupiter · 15 mi lwen
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
Lòt etid nan West Palm Beach
- Maladi Alzheimer13 etid
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè11 etid
- Sipwa9 etid
- Kansè Endomèt8 etid
- Ensifizyans kadyak7 etid
- Twoub depresif majè7 etid
- Skizofreni7 etid
- Maladi kadyovaskilè7 etid
- BPCO6 etid
- VIH6 etid
- Dyabèt Tip 26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.